Product Description: MEDI4276 Antibody is an HER2-targeted antibody, which can be used for the synthesis of the ADC molecule MEDI4276. MEDI4276 Antibody can be used in the study of cancer[1].
Applications: Cancer-Kinase/protease
Formula: N/A
References: [1]Li J, et al. MEDI4276, a HER2-targeting antibody tubulysin conjugate, displays potent in vitro and in vivo activity in preclinical studies[J]. Cancer Research, 2016, 76(14_Supplement): 2970-2970.
Molecular Weight: N/A
Research Area: Cancer
Target: ADC Antibody;EGFR